▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2547 by analyst upside · 2026-06-27
ICUI
ICU Medical, Inc.
Healthcare · Market Cap $4B · P/E 79.7x
ANALYST PRICE TARGET
+16.3%
implied upside to consensus target
Current Price $148.27
Consensus Target $172.5
Bull Target $200.0
Bear Target $160.0
Analysts Covering 8
ANALYST CONSENSUS — BUY
Strong Buy
3
Buy
3
Hold
1
Sell
1
52-Week Low $107.0
52-Week High $160.29
YTD Return +7.0%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) 79.7x
Forward P/E 15.9x
EPS (TTM) $1.86
PEG Ratio 0.08
Dividend Yield N/A
Revenue (TTM) $2.2B
Profit Margin 2.1%
52-WEEK RANGE
52-Week Low $107.0
52-Week High $160.29
Current Price $148.27
Bear Target $160.0
Bull Target $200.0
● Now $148.27 ● Target $172.5
TRADING DATA
Avg Volume 286K
YTD Return +7.0%
Analyst Count 8
Consensus Buy
Upside to Target +16.3%
Last Updated 2026-06-27

ANALYST SUMMARY

ICU Medical, Inc. (ICUI) is currently trading at $148.27 with a Wall Street consensus price target of $172.5, implying potential upside of 16.3% over the next 12 months. 8 analysts currently cover ICUI, with a consensus rating of Buy — 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $200.0, while the most cautious has a target of $160.0.

ICUI operates in the Healthcare sector with a market capitalisation of $4B. The stock is up 7.0% year-to-date and is currently trading near the upper end of its 52-week range of $107.0 – $160.29.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HAE +10.2%
Haemonetics Corporation
$4B · P/E 37.9x · Buy
LIVN -2.3%
LivaNova PLC
$5B · P/E 42.6x · Buy
SHC +16.4%
Sotera Health Company
$5B · P/E 42.4x · Buy
MMSI +24.8%
Merit Medical Systems, Inc.
$4B · P/E 30.9x · Buy
DOCS +21.7%
Doximity, Inc.
$4B · P/E 20.3x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ICUI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BTIG ● Initiated
Buy 2026-06-15 38% win rate (8 calls)
Needham ↑ Upgrade
Hold → Buy 2026-05-27 20% win rate (5 calls)
Keybanc — Reiterated
Overweight → Overweight 2026-04-27 Building track record
Piper Sandler — Reiterated
Overweight → Overweight 2026-04-17 14% win rate (7 calls)
Keybanc — Reiterated
Overweight → Overweight 2026-02-20 Building track record
Piper Sandler — Reiterated
Overweight → Overweight 2026-02-20 14% win rate (7 calls)
Keybanc — Reiterated
Overweight → Overweight 2025-11-07 Building track record
Piper Sandler — Reiterated
Overweight → Overweight 2025-11-07 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →